Researchers report on the long-term immune changes in patients with refractory or relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax and rituximab plus bendamustine and rituximab.
Immunoglobulin A nephropathy (also known as IgA nephropathy or Berger's disease) is a condition that causes IgA antibodies to ...
As for Uplizna, Amgen said that it is initiating regulatory filing activities to set it up for approval to treat MG. Last ...
The treatment with recombinant antibodies and more recently T cell receptor (TCR) engineered T-cell therapies represent two immunological strategies that came into the forefront of clinical interest ...
Immunoglobulin A nephropathy (known as IgA nephropathy or Berger's disease) is a rare kidney disease that occurs when the ...
The Immunoglobulin G4-Related Disease (IgG4-RD) drugs in development market research report provides comprehensive information on the therapeutics under development for Immunoglobulin G4-Related ...
The first is greater demand for plasma products: doctors have found ever more uses for the medicines, especially intravenous immunoglobulin. According to Marketing Research Bureau, a data firm ...